European women health diagnostics market is growing at a CAGR of approximately 9.1% during the forecast period. According to WHO, there are more than 470 million women living in the European Region, representing just over half of the total population. Understanding women’s health is therefore central to understanding the demographic and epidemiological changes, such as aging and migration, occurring in this very diverse Region. In addition, according to the World Bank, GDP of Europe region in 2018 was around $ 18.8 trillion, health expenditure remains the second largest item of general government expenditure after expenditure on social protection. The total expenditure of the general government on health amounted to 9.6 % of GDP. This increases healthcare infrastructure, increases the number of clinical laboratories and diagnostic centres, which is expected to push the European women’s health diagnostics market during the forecasted year.
To Request a Sample of our Report on European Women Health Diagnostics Market: https://www.omrglobal.com/request-sample/european-women-health-diagnostics-market
Further, lifestyle-related disorders is also growing in Europe, smoking prevalence is lower in women than in men, however, this gap has been closing in recent years due to decreasing numbers of men smoking and increasing numbers of women smoking in certain countries, which may lead to severe problems and diseases, which in turn enhances the growth of the European women health diagnostics market during the forecast period. Cardiovascular diseases continue to comprise a major part of the overall disease burden for women, but rates of mental ill-health are increasing throughout the region and across all ages.
(Get 15% Discount on Buying this Report)
A full Report of European Women Health Diagnostics Market is Available at: https://www.omrglobal.com/industry-reports/european-women-health-diagnostics-market
European Women Health Diagnostics Market Segmentation
By Applications
- Breast Cancer Testing
- Cervical Cancer Testing
- Pregnancy & Fertility Testing
- Ovarian Cancer Testing
- Infectious Disease Testing
- Ultrasound Tests
- Sexually Transmitted Disease Testing
- Others (Osteoporosis Testing and Prenatal Genetic Testing)
By End-User
- Diagnostic and Imaging Centers
- Hospitals and Clinics
- Home Care
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
